Reach7 Diabetes Studios

At Reach7, we are pioneering a transformative, exclusive, and unrestrictive care model purpose-built for the rising tide of type 2 diabetes and obesity. Unlike traditional, reactive healthcare systems, Reach7 delivers continuous, relationship-based care that’s personalized, outcomes-driven, and free from insurance limitations. Through our retail-based studios and member-first experience, we combine proven, digitally enabled care strategies, advanced tools, and real human connection to empower individuals—improving healthspan, reducing complications, and delivering measurable results. Why Reach7 Stands Out Disruptive Model -Studio-based access with 24/7 support and precision protocols—not episodic, reactive visits. Proven Value and Uptake -Early traction, strong member engagement, and high satisfaction signal a clear market fit. Scalable Framework -A repeatable, turnkey playbook refined in corporate studios—primed for franchise expansion. Urgent Market Need -38M+ Americans live with diabetes; the endocrinology workforce is shrinking ~8% annually. The system is overburdened and ill-equipped to scale. Predictable Revenue -A cash-pay, recurring revenue model with strong retention and long-term member value. We’re not just improving diabetes and obesity care—we’ve reinvented the entire experience for patients, providers, and employers. We’re now inviting capital partners to help scale a proven model with national potential. Let’s reach further—together.